Search

everythinglearnresearchcommunity

for

Search:↓

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Superoxidized electrolyzed solution (SES) is more effective for burn healing than common antiseptics.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Pertussis toxin may contribute to hair loss in alopecia areata.

The scalp's microorganisms significantly affect hair health and disease.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Targeting macrophages may improve wound healing.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

ILC1-like cells can independently cause alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Composite biodegradable biomaterials can improve diabetic wound healing but need more development for clinical use.

Chitosan–hydroxyapatite biocomposites are promising for tissue engineering due to their safety and ability to support healing.

Functionalized hydrogels can help heal tissues and fight infections by delivering beneficial bacteria and antimicrobials.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.